Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Peripheral Diabetic Neuropathy clinical trials

1 of 1 indexed Peripheral Diabetic Neuropathy trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Peripheral Diabetic Neuropathy: 1 US clinical trial tracked, 1 recruiting.

Peripheral Diabetic Neuropathy is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Averitas Pharma, running 1 of these trials.

Enrollment posture brief

Registry condition peripheral-diabetic-neuropathy

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Peripheral Diabetic Neur (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Peripheral Diabetic Neuropathy

Peripheral Diabetic Neuropathy lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Peripheral Diabetic Neuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Peripheral Diabetic Neuropathy is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Averitas Pharma 1 trials

Named interventions

Most-linked intervention names on Peripheral Diabetic Neuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Capsaicin 8% Drug
1 trials

US sites by state

Facility locations filed on Peripheral Diabetic Neuropathy trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Ohio 1 trials
New Jersey 1 trials
Kentucky 1 trials
Georgia 1 trials
Delaware 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Peripheral Diabetic Neuropathy page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Peripheral Diabetic Neuropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Averitas Pharma sponsors the most Peripheral Diabetic Neuropathy trials on record, review their full trial history before evaluating a specific study. See Averitas Pharma's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Diabetic Neuropathy condition card totals 1 registered trials; most-linked intervention Capsaicin 8%; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.